CardioSyntax

Curated by Signal

Developer of therapeutics for heart diseases based on an algorithm

Overview

Developer of therapeutics for heart diseases based on an algorithm. It offers software for 3D mapping and navigation systems in cardiovascular applications in the field of diagnostics and therapy.

Key facts

Founded: 2017
Headquarters: Germany
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Matchpharm
Provider of COVID-19 antigen rapid tests for point-of-care use
Health TechnologyMunich, Germany
Prediction2020
Provider of AI-based clinical decision support platform for neurologists
Health TechnologyBerlin, Germany
Nutritionevents
Provider of an online networking and collaborative platform for medical experts
Health TechnologyBad Homburg, Germany

About CardioSyntax

What does CardioSyntax do?

Developer of therapeutics for heart diseases based on an algorithm.

Where is CardioSyntax headquartered?

CardioSyntax is headquartered in Germany.

When was CardioSyntax founded?

CardioSyntax was founded in 2017.

Which sector is CardioSyntax in?

CardioSyntax operates in Health Technology.

Who are CardioSyntax's competitors?

Companies similar to CardioSyntax include Matchpharm, Prediction2020, and Nutritionevents.